R.I. Lalisang
Department of Internal Medicine
Maastricht University Hospital
Netherlands
Name/email consistency: high
- Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer. Lalisang, R.I., Wils, J.A., Nortier, H.W., Burghouts, J.T., Hupperets, P.S., Erdkamp, F.L., Schouten, H.C., Blijham, G.H. J. Clin. Oncol. (1997)